Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11058678 Substituted heterocycles as antiviral agents

Patent 11058678 was granted and assigned to Enanta Pharmaceuticals on July, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Enanta Pharmaceuticals

Current Assignee

Enanta Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

110586780

Patent Inventor Names

Joseph Panarese0

Katherine Chong0

Samuel Bartlett0

Yat Sun Or0

Date of Patent

July 13, 2021

Patent Application Number

162513860

Date Filed

January 18, 2019

Patent Citations

‌

US Patent 10253030 Crystal form, preparation method and intermediate of dihydropyrido ring compound

‌

US Patent 10179131 Hepatitis B antiviral agents

‌

US Patent 10189846 Hepatitis B antiviral agents

‌

US Patent 10428070 Hepatitis B antiviral agents

Patent Citations Received

‌

US Patent 12011425 Hepatitis B antiviral agents

‌

US Patent 11802125 Functionalized heterocyclic compounds as antiviral agents

‌

US Patent 11891393 Functionalized heterocycles as antiviral agents

Patent Primary Examiner

‌

Timothy R Rozof

Patent abstract

The present invention discloses compounds of Formula (I), and pharmaceutically acceptable salts thereof:

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11058678 Substituted heterocycles as antiviral agents

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API